Akram Rezaei

Akram Rezaei

Auto-generated profile, based on publicly available information

Akram Rezaei

Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
PDF file
SAShabnam Zeighamy Alamdary
Shabnam Zeighamy Alamdary
SHShahnaz Halimi
Shahnaz Halimi
ARAkram Rezaei
Akram Rezaei
RARoghayeh Afifirad
Roghayeh Afifirad
Background. Colorectal cancer (CRC) is one of the most prevalent gastrointestinal malignancies and is considered the third major cause of mortality globally. Probiotics have been shown to protect against the CRC cascade in numerous studies. Aims. The goal of this systematic review was to gather the preclinical studies that examined the impact of probiotics on the alteration of gut microbiota profiles (bacterial communities) and their link to colorectal carcinogenesis as well as the potential processes involved. Methods. The search was performed using Scopus, Web of Science, and PubMed databases. Five parameters were used to develop search filters: “probiotics,” “prebiotics,” “synbiotics,” “colorectal cancer,” and “animal model.” Results. Of the 399 full texts that were screened, 33 original articles met the inclusion criteria. According to the current findings, probiotics/synbiotics could significantly attenuate aberrant crypt foci (ACF) formation, restore beneficial bacteria in the microbiota population, increase short‐chain fatty acids (SCFAs), and change inflammatory marker expression. Conclusions. The present systematic review results indicate that probiotics could modulate the gut microbial composition and immune regulation to combat/inhibit CRC in preclinical models. However, where the evidence is more limited, it is critical to transfer preclinical research into clinical data.

1 January 2024 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
Erfaneh JafariErfaneh Jafari
Erfaneh Jafari
NSNiloufar Soleymani
Niloufar Soleymani
MHMasoud Hamidi
Masoud Hamidi
ARAzar Rahi
Azar Rahi
ARAkram Rezaei
Akram Rezaei
Reza AzizianReza Azizian
Reza Azizian
Celiac disease (CD) is a complex disorder influenced by genetic and environmental factors. When people with a genetic predisposition to CD consume gluten, an inflammatory response is triggered in the small intestine, and this reaction can be alleviated by the elimination of gluten from the diet. The clinical manifestations of CD vary ...